Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33

References

• Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and Induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479–490. doi:10.1016/j.immuni.2005.09.015
   PubMed Web of Science ®Google Scholar
• Moussion C, Ortega N, Girard J-P. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: a Novel ‘Alarmin’? PLoS One. 2008;3(10):e3331. doi:10.1371/journal.pone.0003331
   PubMed Web of Science ®Google Scholar
• Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10(2):103–110. doi:10.1038/nri2692
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard J-P. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev. 2018;281(1):154–168. doi:10.1111/imr.12619
   PubMed Web of Science ®Google Scholar
• Carriere V, Roussel L, Ortega N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A. 2007;104(1):282–287. doi:10.1073/pnas.0606854104
   PubMed Web of Science ®Google Scholar
• Roussel L, Erard M, Cayrol C, Girard JP. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 2008;9(10):1006–1012. doi:10.1038/embor.2008.145
   PubMed Web of Science ®Google Scholar
• Lefrancais E, Roga S, Gautier V, et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A. 2012;109(5):1673–1678. doi:10.1073/pnas.1115884109
   PubMed Web of Science ®Google Scholar
• Lefrancais E, Duval A, Mirey E, et al. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci U S A. 2014;111(43):15502–15507. doi:10.1073/pnas.1410700111
   PubMed Web of Science ®Google Scholar
• Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007;179(4):2551–2555. doi:10.4049/jimmunol.179.4.2551
   PubMed Web of Science ®Google Scholar
• Palmer G, Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol. 2011;7(6):321–329. doi:10.1038/nrrheum.2011.53
   PubMed Web of Science ®Google Scholar
• Yang Q, Li G, Zhu Y, et al. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol. 2011;41(11):3351–3360. doi:10.1002/eji.201141629
   PubMed Web of Science ®Google Scholar
• Suzukawa M, Iikura M, Koketsu R, et al. An IL-1 cytokine member, IL-33, induces human basophil activation via Its ST2 Receptor. J Immunol. 2008;181(9):5981–5989. doi:10.4049/jimmunol.181.9.5981
   PubMed Web of Science ®Google Scholar
• Pushparaj PN, Tay HK, H’ng SC, et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Nat Acad Sci. 2009;106(24):9773–9778. doi:10.1073/pnas.0901206106
   PubMed Web of Science ®Google Scholar
• Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol. 2010;185(6):3472–3480. doi:10.4049/jimmunol.1000730
   PubMed Web of Science ®Google Scholar
• Koyasu S, Moro K. Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population. Curr Opin Allergy Clin Immunol. 2011;11(2):109–114. doi:10.1097/ACI.0b013e3283448808
   PubMed Web of Science ®Google Scholar
• Chang YJ, Kim HY, Albacker LA, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011;12(7):631–638. doi:10.1038/ni.2045
   PubMed Web of Science ®Google Scholar
• Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009;123(5):1047–1054. doi:10.1016/j.jaci.2009.02.026
   PubMed Web of Science ®Google Scholar
• Drake LY, Prakash YS. Contributions of IL-33 in non-hematopoietic lung cells to obstructive lung disease. Front Immunol. 2020;2:11.
   Google Scholar
• Hsu CL, Neilsen CV, Bryce PJ. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One. 2010;5(8):e11944. doi:10.1371/journal.pone.0011944
   PubMed Web of Science ®Google Scholar
• Kondo Y, Yoshimoto T, Yasuda K, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol. 2008;20(6):791–800. doi:10.1093/intimm/dxn037
   PubMed Web of Science ®Google Scholar
• Izuhara K, Ohta S, Shiraishi H, et al. The mechanism of mucus production in bronchial asthma. Curr Med Chem. 2009;16(22):2867–2875. doi:10.2174/092986709788803196
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Leung DYM. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233–246. doi:10.1111/j.1600-065X.2011.01027.x
   PubMed Web of Science ®Google Scholar
• Imai Y. Interleukin-33 in atopic dermatitis. J Dermatol Sci. 2019;96(1):2–7. doi:10.1016/j.jdermsci.2019.08.006
   PubMed Web of Science ®Google Scholar
• Savenije OE, Mahachie John JM, Granell R, et al. Association of IL33–IL-1 receptor–like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol. 2014;134(1):170–177.
   PubMed Web of Science ®Google Scholar
• Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Eng J Med. 2010;363(13):1211–1221. doi:10.1056/NEJMoa0906312
   PubMed Web of Science ®Google Scholar
• Ober C, Nicolae DL. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet. 2011;43(9):887–892. doi:10.1038/ng.888
   PubMed Web of Science ®Google Scholar
• Tamari M, Hirota T. Genome-wide association studies of atopic dermatitis. J Dermatol. 2014;41(3):213–220. doi:10.1111/1346-8138.12321
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y, Zhang L. Discovering susceptibility genes for allergic rhinitis and allergy using a genome-wide association study strategy. Curr Opin Allergy Clin Immunol. 2015;15(1):33–40. doi:10.1097/ACI.0000000000000124
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis MA, Siedlinski M, Van Den Berge M, et al. Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma. Allergy. 2016;71(12):1712–1720. doi:10.1111/all.12990
   PubMed Web of Science ®Google Scholar
• Portelli MA, Dijk FN, Ketelaar ME, et al. Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium. JCI Insight. 2020;5(8). doi:10.1172/jci.insight.132446
   PubMed Web of Science ®Google Scholar
• Oboki K, Ohno T, Kajiwara N, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Nat Acad Sci. 2010;107(43):18581–18586. doi:10.1073/pnas.1003059107
   PubMed Web of Science ®Google Scholar
• Komai-Koma M, Xu D, Li Y, McKenzie ANJ, McInnes IB, Liew FY. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol. 2007;37(10):2779–2786. doi:10.1002/eji.200737547
   PubMed Web of Science ®Google Scholar
• Li Y, Chen S, Chi Y, et al. Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16. Cell Mol Immunol. 2019;16(1):75–86. doi:10.1038/s41423-018-0182-0
   PubMed Web of Science ®Google Scholar
• Imai Y, Yasuda K, Sakaguchi Y, et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A. 2013;110(34):13921–13926. doi:10.1073/pnas.1307321110
   PubMed Web of Science ®Google Scholar
• Liu B, Tai Y, Achanta S, et al. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc Nat Acad Sci. 2016;113(47):E7572–E7579. doi:10.1073/pnas.1606608113
   PubMed Web of Science ®Google Scholar
• Angal S, King DJ, Bodmer MW, et al. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol. 1993;30(1):105–108. doi:10.1016/0161-5890(93)90432-B
   PubMed Web of Science ®Google Scholar
• Xu D, Alegre ML, Varga SS, et al. In vitro characterization of five humanized OKT3 effector function variant antibodies. Cell Immunol. 2000;200(1):16–26. doi:10.1006/cimm.2000.1617
   PubMed Web of Science ®Google Scholar
• Wu H, Pfarr DS, Tang Y, et al. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. J Mol Biol. 2005;350(1):126–144. doi:10.1016/j.jmb.2005.04.049
   PubMed Web of Science ®Google Scholar
• Okragly AJ, Morin SM, Derosa D, et al. Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP). Cephalalgia. 2018;38(9):1564–1574. doi:10.1177/0333102417740563
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Smith D, Comeau M, Delespesse G. Cutting Edge: the ST2 Ligand IL-33 Potently activates and drives maturation of human mast cells. J Immunol. 2007;179:2051–2054. doi:10.4049/jimmunol.179.4.2051
   PubMed Web of Science ®Google Scholar
• Joulia R, L’Faqihi FE, Valitutti S, Espinosa E. IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level. J Allergy Clin Immunol. 2017;140(2):497–509.e410. doi:10.1016/j.jaci.2016.09.049
   PubMed Web of Science ®Google Scholar
• Cohen ES, Scott IC, Majithiya JB, et al. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. J Allergy Clin Immunol. 2015;6:8327.
   Google Scholar
• Morita H, Nakae S, Saito H, Matsumoto K. IL-33 in clinical practice: size matters? J Allergy Clin Immunol. 2017;140(2):381–383. doi:10.1016/j.jaci.2017.03.042
   PubMed Web of Science ®Google Scholar
• Lingel A, Weiss TM, Niebuhr M, et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors–insight into heterotrimeric IL-1 signaling complexes. Structure. 2009;17(10):1398–1410. doi:10.1016/j.str.2009.08.009
   PubMed Web of Science ®Google Scholar
• Consortium TU. UniProt: a hub for protein information. Nucleic Acids Res. 2014;43(D1):D204–D212.
   PubMed Web of Science ®Google Scholar
• Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10(2):103–110.
   PubMed Web of Science ®Google Scholar
• Mueller T, Dieplinger B. The Presage ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2. Expert Rev Mol Diagn. 2013;13(1):13–30. doi:10.1586/erm.12.128
   PubMed Web of Science ®Google Scholar
• Schwartz C, O’Grady K, Lavelle EC, Fallon PG. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer. Eur J Immunol. 2016;46(5):1091–1100. doi:10.1002/eji.201545780
   PubMed Web of Science ®Google Scholar
• Latiano A, Palmieri O, Pastorelli L, et al. Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS One. 2013;8(4):e62144. doi:10.1371/journal.pone.0062144
   PubMed Web of Science ®Google Scholar
• Sun BB, Ma LJ, Qi Y, Zhang GJ. Correlation of IL-33 gene polymorphism with chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci. 2019;23(14):6277–6282.
   PubMed Web of Science ®Google Scholar
• Koca SS, Pehlivan Y, Kara M, et al. The IL-33 gene is related to increased susceptibility to systemic sclerosis. Rheumatol Int. 2016;36(4):579–584. doi:10.1007/s00296-015-3417-8
   PubMed Web of Science ®Google Scholar
• Li C, Mu R, Guo J, et al. Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis. Arthritis Res Ther. 2014;16(2):R105. doi:10.1186/ar4554
   PubMed Web of Science ®Google Scholar
• Guo J, Xiang Y, Peng Y-F, Huang H-T, Lan Y, Wei Y-S. The association of novel IL-33 polymorphisms with sIL-33 and risk of systemic lupus erythematosus. Mol Immunol. 2016;77:1–7. doi:10.1016/j.molimm.2016.07.001
   PubMed Web of Science ®Google Scholar
• Xu W, Liu Y, Ye D. Association between IL-33 Gene Polymorphisms (rs1929992, rs7044343) and Systemic Lupus Erythematosus in a Chinese Han Population. Immunol Invest. 2016;45(7):575–583. doi:10.1080/08820139.2016.1193868
   PubMed Web of Science ®Google Scholar